Development of Encorafenib for BRAF-mutated Advanced Melanoma
Current Opinion in Oncology - United States
doi 10.1097/cco.0000000000000426
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2018
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)